查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609806

2024-2032 年日本神经调节市场报告（按技术、生物材料、应用和地区）

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023年日本神经调节IMARC Group规模达3.082亿美元。日本老年人口的不断增加、最新的技术进步、医疗保健支出的增加、对神经调节益处的认识提高、主要市场参与者的强大存在以及优惠报销政策的推出是推动市场的一些关键因素。

神经调节是指透过向神经系统的目标区域传递药物或电剂来改变神经活动的技术。它涵盖多种类型，包括脊髓刺激、脑部深部刺激、荐神经刺激和周边神经刺激。神经调节由多个组件组成，例如脉衝产生器、电极和用于编程的手持设备。它提供多种功能，包括微创手术、可自订的治疗设定和即时回馈机制。神经调节广泛用于治疗慢性疼痛、癫痫、运动障碍、精神疾病、偏头痛和胃肠道问题。它提供标靶治疗、与全身给药相比副作用减少、可逆性以及远端患者监测的潜力。此外，神经调节还具有多种优势，例如增强患者依从性、提高生活品质、长期成本效益以及即时调整治疗设定的机会。

日本神经调节市场趋势：

日本老年人口的不断增加，导致神经系统和慢性疾病的发病率不断上升，从而推动了市场的成长。此外，最近的技术进步（例如无线神经调节的出现）扩大了该技术的应用，从而推动了市场的成长。除此之外，医疗保健支出的增加和神经学研究的优先化，为市场扩张创造了有利的环境，是另一个成长诱导因素。此外，人们对神经调节益处的认识不断提高，从而促进了更快的采用率，从而促进了市场的成长。除此之外，日本主要市场参与者的强大影响力和频繁的产品发布正在刺激市场成长。除此之外，政府医疗保健系统针对神经调节手术推出的优惠报销政策正在促进市场成长。此外，透过临床试验越来越多的证据表明神经调节的功效，进一步证明了该技术的可信度，正在对市场成长产生积极影响。同时，对微创手术的广泛需求促进了神经调节的应用，支撑了市场的成长。与此一致的是，神经调节领域熟练的医疗保健专业人员数量的不断增加正在推动市场的成长。此外，用于即时调整和监控的人工智慧（AI）的整合正在为市场成长创造积极的前景。此外，患者对神经调节的依从性和满意度不断提高，鼓励更多转诊，正在加速市场成长。除此之外，主要参与者之间不断增加的策略合作和收购，以扩大进一步的研究并利用共享的专业知识，正在加强市场的成长。此外，公共和私人对研发（R＆D）活动的​​投资不断增长也推动了市场的成长。

日本神经调节市场细分：

技术见解：

  • 内部神经调节
  • 脊髓刺激 (SCS)
  • 深部脑部刺激 (DBS)
  • 迷走神经刺激 (VNS)
  • 荐神经刺激 (SNS)
  • 胃电刺激 (GES)
  • 外部神经调节
  • 经皮电神经刺激 (TENS)
  • 经颅磁刺激 (TMS)
  • 其他的

生物材料见解：

  • 金属生物材料
  • 高分子生物材料
  • 陶瓷生物材料

应用见解：

  • 帕金森氏症
  • 癫痫
  • 沮丧
  • 肌张力失调
  • 疼痛管理
  • 其他的

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 到目前为止，日本神经调节市场的表现如何，未来几年又会如何表现？
  • COVID-19 对日本神经调节市场有何影响？
  • 日本神经调节市场在技术上的分化是什么？
  • 日本基于生物材料的神经调节市场的分化是什么？
  • 日本神经调节市场在应用上的细分如何？
  • 日本神经调节市场价值链的各个阶段是什么？
  • 日本神经调节的关键驱动因素和挑战是什么？
  • 日本神经调节市场的结构如何？
  • 日本神经调节市场的竞争程度如何？

本报告回答的关键问题：

  • 到目前为止，日本神经调节市场的表现如何，未来几年又会如何表现？
  • COVID-19 对日本神经调节市场有何影响？
  • 日本神经调节市场在技术上的分化是什么？
  • 日本基于生物材料的神经调节市场的分化是什么？
  • 日本神经调节市场在应用上的细分如何？
  • 日本神经调节市场价值链的各个阶段是什么？
  • 日本神经调节的关键驱动因素和挑战是什么？
  • 日本神经调节市场的结构如何？
  • 日本神经调节市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本神经调节市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本神经调节市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本神经调节市场 - 细分：技术

  • 内部神经调节
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔
      • 脊髓刺激 (SCS)
      • 深部脑部刺激 (DBS)
      • 迷走神经刺激 (VNS)
      • 荐神经刺激 (SNS)
      • 胃电刺激 (GES)
    • 市场预测（2024-2032）
  • 外部神经调节
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔
      • 经皮电神经刺激 (TENS)
      • 经颅磁刺激 (TMS)
      • 其他的
    • 市场预测（2024-2032）

第 7 章：日本神经调节市场 - 分解：生物材料

  • 金属生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 高分子生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 陶瓷生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 8 章：日本神经调节市场 - 细分：依应用分类

  • 帕金森氏症
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 癫痫
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 沮丧
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 肌张力失调
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 疼痛管理
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本神经调节市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 10 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本神经调节市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112024A19378

Japan neuromodulation market size reached US$ 308.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 925.5 Million by 2032, exhibiting a growth rate (CAGR) of 13.30% during 2024-2032. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

  • Internal Neuromodulation
  • Spinal Cord Stimulation (SCS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Sacral Nerve Stimulation (SNS)
  • Gastric Electrical Stimulation (GES)
  • External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Magnetic Stimulation (TMS)
  • Others

Biomaterial Insights:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

Application Insights:

  • Parkinson's Disease
  • Epilepsy
  • Depression
  • Dystonia
  • Pain Management
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neuromodulation market?
  • What is the breakup of the Japan neuromodulation market on the basis of technology?
  • What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
  • What is the breakup of the Japan neuromodulation market on the basis of application?
  • What are the various stages in the value chain of the Japan neuromodulation market?
  • What are the key driving factors and challenges in the Japan neuromodulation?
  • What is the structure of the Japan neuromodulation market and who are the key players?
  • What is the degree of competition in the Japan neuromodulation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Neuromodulation Market - Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Spinal Cord Stimulation (SCS)
      • 6.1.3.2 Deep Brain Stimulation (DBS)
      • 6.1.3.3 Vagus Nerve Stimulation (VNS)
      • 6.1.3.4 Sacral Nerve Stimulation (SNS)
      • 6.1.3.5 Gastric Electrical Stimulation (GES)
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 External Neuromodulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.3.3 Others
    • 6.2.4 Market Forecast (2024-2032)

7 Japan Neuromodulation Market - Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Neuromodulation Market - Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Depression
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Dystonia
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2018-2023)
    • 8.6.2 Market Forecast (2024-2032)

9 Japan Neuromodulation Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Neuromodulation Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix